FASEB J. Avanti Polar Lipids
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.06-7717com.
(The FASEB Journal. 2007;21:2798-2806.)
© 2007 FASEB
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
fj.06-7717comv1
fj.06-7717comv2
21/11/2798    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Siegmund, S. V.
Right arrow Articles by Schwabe, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Siegmund, S. V.
Right arrow Articles by Schwabe, R. F.

The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species

Sören V. Siegmund*,{dagger}, Ting Qian{ddagger}, Samuele de Minicis*, Judith Harvey-White§, George Kunos§, K. Y. Vinod||, Basalingappa Hungund|| and Robert F. Schwabe*

* Department of Medicine, Columbia University, College of Physicians and Surgeons, New York, New York, USA;

{dagger} Department of Medicine II, Medical Faculty at Mannheim, University of Heidelberg, Mannheim, Germany;

{ddagger} Department of Neuroscience and Cell Biology, University of Texas Medical Branch, Galveston, Texas, USA;

§ National Institute on Alcohol Abuse and Alcoholism, National Institute of Health, Bethesda, Maryland, USA;

|| Nathan Kline Institute for Psychiatric Research, Orangeburg, New York, USA; and

Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, New York, USA

1Correspondence: Columbia University, Russ Berrie Pavillion, Rm. 415, 1150 St. Nicholas Ave, New York, NY, USA 10032. E-mail: rfs2102{at}columbia.edu

The endocannabinoid system is an important regulator of hepatic fibrogenesis. In this study, we determined the effects of 2-arachidonoyl glycerol (2-AG) on hepatic stellate cells (HSCs), the main fibrogenic cell type in the liver. Culture-activated HSCs were highly susceptible to 2-AG-induced cell death with >50% cell death at 10 µM after 18 h of treatment. 2-AG-induced HSC death showed typical features of apoptosis such as PARP- and caspase 3-cleavage and depended on reactive oxygen species (ROS) formation. Confocal microscopy revealed mitochondria as primary site of ROS production and demonstrated mitochondrial depolarization and increased mitochondrial permeability after 2-AG treatment. 2-AG-induced cell death was independent of cannabinoid receptors but required the presence of membrane cholesterol. Primary hepatocytes were resistant to 2-AG-induced ROS induction and cell death but became susceptible after GSH depletion suggesting antioxidant defenses as a critical determinant of 2-AG sensitivity. Hepatic levels of 2-AG were significantly elevated in two models of experimental fibrogenesis and reached concentrations that are sufficient to induce death in HSCs. These findings suggest that 2-AG may act as an antifibrogenic mediator in the liver by inducing cell death in activated HSCs but not hepatocytes.—Siegmund, S. V., Qian, T., de Minicis, S., Harvey-White, J., Kunos, G., Vinod, K. Y., Hungund, B., Schwabe, R. F. The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species.


Key Words: ROS • 2-AG • HSC • hepatocyte • fibrosis




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
K. H. Han, S. Lim, J. Ryu, C.-W. Lee, Y. Kim, J.-H. Kang, S.-S. Kang, Y. K. Ahn, C.-S. Park, and J. J. Kim
CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages
Cardiovasc Res, December 1, 2009; 84(3): 378 - 386.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
E. Garcia-Gonzalez, E. Selvi, E. Balistreri, S. Lorenzini, R. Maggio, M.-R. Natale, P.-L. Capecchi, P.-E. Lazzerini, M. Bardelli, F. Laghi-Pasini, et al.
Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts
Rheumatology, September 1, 2009; 48(9): 1050 - 1056.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Kunos, D. Osei-Hyiaman, J. Liu, G. Godlewski, and S. Batkai
Endocannabinoids and the Control of Energy Homeostasis
J. Biol. Chem., November 28, 2008; 283(48): 33021 - 33025.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
A A Izzo and M Camilleri
Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects
Gut, August 1, 2008; 57(8): 1140 - 1155.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
V. L. Hegde, S. Hegde, B. F. Cravatt, L. J. Hofseth, M. Nagarkatti, and P. S. Nagarkatti
Attenuation of Experimental Autoimmune Hepatitis by Exogenous and Endogenous Cannabinoids: Involvement of Regulatory T Cells
Mol. Pharmacol., July 1, 2008; 74(1): 20 - 33.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Hisatsune, M. Nakayama, H. Isomoto, H. Kurazono, N. Mukaida, A. K. Mukhopadhyay, T. Azuma, Y. Yamaoka, J. Sap, E. Yamasaki, et al.
Molecular Characterization of Helicobacter pylori VacA Induction of IL-8 in U937 Cells Reveals a Prominent Role for p38MAPK in Activating Transcription Factor-2, cAMP Response Element Binding Protein, and NF-{kappa}B Activation
J. Immunol., April 1, 2008; 180(7): 5017 - 5027.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. V. Siegmund and R. F. Schwabe
Endocannabinoids and Liver Disease. II. Endocannabinoids in the pathogenesis and treatment of liver fibrosis
Am J Physiol Gastrointest Liver Physiol, February 1, 2008; 294(2): G357 - G362.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
S. L. Friedman
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Physiol Rev, January 1, 2008; 88(1): 125 - 172.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
A. Mallat and S. Lotersztajn
Endocannabinoids and Liver Disease. I. Endocannabinoids and their receptors in the liver
Am J Physiol Gastrointest Liver Physiol, January 1, 2008; 294(1): G9 - G12.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by The Federation of American Societies for Experimental Biology.